Perforin and the granule exocytosis cytotoxicity pathway

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 522-527

  Catalfamo, Marta ^a   Henkart, Pierre A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BACTERIAL TOXIN; CALCIUM; CASPASE; CATHEPSIN B; CD8 ANTIGEN; CYTOKINE; FAS LIGAND; GRANZYME A; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN; PROTEIN INHIBITOR; PROTEIN P53; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; STREPTOLYSIN O; VACCINE;

ANTIGEN PRESENTING CELL; APOPTOSIS; CELL DEATH; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CHANNEL GATING; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DEGRANULATION; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; EXOCYTOSIS; FAMILIAL DISEASE; FAMILIAL HEMATOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; GRANULE CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; IN VIVO STUDY; LISTERIOSIS; LYMPHOMA; MAST CELL; MEASUREMENT; MEMBRANE PERMEABILITY; MOLECULAR MECHANICS; MUTATION; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TARGET CELL;

EID: 0141741400     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00114-6     Document Type: Review

References (53)

1. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 20:2002;323-370.
2. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2:2002;401-409.
3. Clark R, Griffiths G: Lytic granules, secretory lysosomes and disease. Curr Opin Immunol 2003, 15: 516-521.
4. Trapani JA, Sutton VR: Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003, 15: 533-543.
5. Lieberman J, Fan Z: Nuclear war: the granzyme a bomb. Curr Opin Immunol 2003, 15: 553-559.
6. Grossman WJ, Revell PA, Lu ZH, Johnson H, Bredemeyer AJ, Ley TJ: The orphan granzymes of humans and mice. Curr Opin Immunol 2003, 15: 544-552.
7. Kägi D., Ledermann B., Bürki K., Zinkernagel R.M., Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 14:1996;207-232.
8. Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 192:2000;755-760.
9. Trapani J.A., Smyth M.J. Functional significance of the perforin/ granzyme cell death pathway. Nat Rev Immunol. 2:2002;735-747.
10. Hayakawa Y., Kelly J.M., Westwood J.A., Darcy P.K., Diefenbach A., Raulet D., Smyth M.J. Tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J Immunol. 169:2002;5377-5381.
11. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., Schreiber R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 3:2002;991-998.
12. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G.et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 286:1999;1957-1959.
13. de Saint Basile G., Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol. 13:2001;549-554.
14. Kagi D., Odermatt B., Mak T.W. Homeostatic regulation of CD8+ T cells by perforin. Eur J Immunol. 29:1999;3262-3272.
15. Spaner D., Raju K., Rabinovich B., Miller R.G. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. J Immunol. 162:1999;1192-1199.
16. Harty J.T., Badovinac V.P. Influence of effector molecules on the CD8(+) T cell response to infection. Curr Opin Immunol. 14:2002;360-365.
17. Sad S., Kagi D., Mosmann T.R. Perforin and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation. J Exp Med. 184:1996;1543-1547.
18. Badovinac V.P., Tvinnereim A.R., Harty J.T. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science. 290:2000;1354-1358.
19. Badovinac V.P., Hamilton S.E., Harty J.T. Viral infection results in massive CD8(+) T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity. 18:2003;463-474 This paper shows that previously immunized, but not naïve, perforin knockout mice die in response to a normally benign LCMV challenge, suggesting an explanation for the fatal FHL disease in perforin-deficient humans.
20. Zhou S., Ou R., Huang L., Moskophidis D. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J Virol. 76:2002;829-840.
21. Wong P., Pamer E.G. Feedback regulation of pathogen-specific T cell priming. Immunity. 18:2003;499-511 This paper makes a good case for CTL elimination of APCs in immune responses in vivo.
22. Badovinac V.P., Porter B.B., Harty J.T. Programmed contraction of CD8(+) T cells after infection. Nat Immunol. 3:2002;619-626.
23. Medema J.P., Schuurhuis D.H., Rea D., van Tongeren J., de Jong J., Bres S.A., Laban S., Toes R.E., Toebes M., Schumacher T.N.et al. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med. 194:2001;657-667.
24. Ludewig B., Bonilla W.V., Dumrese T., Odermatt B., Zinkernagel R.M., Hengartner H. Perforin-independent regulation of dendritic cell homeostasis by CD8(+) T cells in vivo: implications for adaptive immunotherapy. Eur J Immunol. 31:2001;1772-1779.
25. Hwang I., Huang J.F., Kishimoto H., Brunmark A., Peterson P.A., Jackson M.R., Surh C.D., Cai Z., Sprent J. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J Exp Med. 191:2000;1137-1148.
26. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 15:2001;751-761.
27. Uellner R., Zvelebil M.J., Hopkins J., Jones J., MacDougall L.K., Morgan B.P., Podack E., Waterfield M.D., Griffiths G.M. Perforin is activated by proteolytic cleavage during biosynthesis which reveals a phospholipid binding domain. EMBO J. 16:1997;7287-7296.
28. Montoya M., Gouaux E. Beta-barrel membrane protein folding and structure viewed through the lens of alpha-hemolysin. Biochim Biophys Acta. 1609:2003;19-27.
29. Henkart P.A. Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 3:1985;31-58.
30. Simone C.B., Henkart P. Permeability changes induced in erythrocyte ghost targets by antibody-dependent cytotoxic effector cells: evidence for membrane pores. J Immunol. 124:1980;954-963.
31. Raja S.M., Wang B., Dantuluri M., Desai U.R., Demeler B., Spiegel K., Metkar S.S., Froelich C.J. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem. 277:2002;49523-49530.
32. Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity. 16:2002;417-428 This paper shows that granzyme B is tightly complexed to proteoglycan after exocytosis, and argues against perforin-mediated pores as the mechanism of granzyme entry into target cells.
33. Shiver J.W., Henkart P.A. A noncytotoxic mast cell tumor line exhibits potent IgE- dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell. 62:1991;1174-1181.
34. Togo T., Alderton J.M., Bi G.Q., Steinhardt R.A. The mechanism of facilitated cell membrane resealing. J Cell Sci. 112:1999;719-731.
35. Bashford C.L., Menestrina G., Henkart P.A., Pasternak C.A. Cell damage by cytolysin: Spontaneous recovery and reversible inhibition by divalent cations. J Immunol. 141:1988;3965-3974.
36. Walev I., Bhakdi S.C., Hofmann F., Djonder N., Valeva A., Aktories K., Bhakdi S. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci USA. 98:2001;3185-3190.
37. Jaiswal J.K., Andrews N.W., Simon S.M. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol. 159:2002;625-635.
38. Froelich C.J., Orth K., Turbov J., Seth P., Gottlieb R., Babior B., Shah G.M., Bleackley R.C., Dixit V.M., Hanna W. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem. 271:1996;29073-29079.
39. Sarin A., Williams M.S., Alexander-Miller M.A., Berzofsky J.A., Zacharchuk C.M., Henkart P.A. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity. 6:1997;209-215.
40. Sarin A., Haddad E.K., Henkart P.A. Caspase dependence of target cell damage induced by cytotoxic lymphocytes. J Immunol. 161:1998;2810-2816.
41. Nakajima H., Henkart P.A. Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J Immunol. 152:1994;1057-1063.
42. Wagner L., Avery R.K., Bensinger L., Hibberd P.L., Pasternack M.S. Inhibition of cytotoxic T-lymphocyte-triggered apoptosis by target cell surface-coupled aprotinin. Mol Immunol. 32:1995;853-864.
43. Sun J., Bird C.H., Sutton V., McDonald L., Coughlin P.B., DeJong T.A., Trapani J.A., Bird P.I. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem. 271:1996;27802-27809.
44. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W.et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 276:2001;33293-33296.
45. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., Bird P.I. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B- mediated apoptosis without perturbing the fas cell death pathway. Mol Cell Biol. 18:1998;6387-6398.
46. Bird C.H., Blink E.J., Hirst C.E., Buzza M.S., Steele P.M., Sun J., Jans D.A., Bird P.I. Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol Cell Biol. 21:2001;5396-5407.
47. Buzza M.S., Hirst C.E., Bird C.H., Hosking P., McKendrick J., Bird P.I. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol. 210:2001;21-29.
48. Bladergroen B.A., Strik M.C., Bovenschen N., van Berkum O., Scheffer G.L., Meijer C.J., Hack C.E., Kummer J.A. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol. 166:2001;3218-3225.
49. Hirst C.E., Buzza M.S., Bird C.H., Warren H.S., Cameron P.U., Zhang M., Ashton-Rickardt P.G., Bird P.I. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol. 170:2003;805-815.
50. Bladergroen B.A., Meijer C.J., ten Berge R.L., Hack C.E., Muris J.J., Dukers D.F., Chott A., Kazama Y., Oudejans J.J., van Berkum O.et al. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood. 99:2002;232-237.
51. + cytotoxic T lymphocytes is due to fratricide. J Immunol. 151:1993;658-667.
52. Hanon E., Stinchcombe J.C., Saito M., Asquith B.E., Taylor G.P., Tanaka Y., Weber J.N., Griffiths G.M., Bangham C.R. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 13:2000;657-664.
53. Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med. 196:2002;493-503 This paper addresses the long-standing CTL selfprotection dilemma, showing that a membrane form of cathepsin B protects cytotoxic lymphocytes after degranulation.